Detalhe da pesquisa
1.
High-throughput identification of regulatory elements and functional assays to uncover susceptibility genes for nasopharyngeal carcinoma.
Am J Hum Genet
; 110(7): 1162-1176, 2023 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352861
2.
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis.
Lancet Oncol
; 24(6): 611-623, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269842
3.
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 24(7): 798-810, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290468
4.
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial.
BMC Med
; 21(1): 94, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927541
5.
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study.
BMC Med
; 21(1): 464, 2023 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012705
6.
Phosphorylation of androgen receptor by mTORC1 promotes liver steatosis and tumorigenesis.
Hepatology
; 75(5): 1123-1138, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34435708
7.
Clinical characteristics and prognostic factors affecting survival after radical radiotherapy for early and late post-treatment metastatic nasopharyngeal carcinoma.
BMC Cancer
; 23(1): 7, 2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597072
8.
Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.
Eur Radiol
; 33(5): 3682-3692, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36735041
9.
Head and neck MRI-based T stage and [18F]FDG PET/CT-based N/M stage improved prognostic stratification in primary nasopharyngeal carcinoma.
Eur Radiol
; 33(11): 7952-7966, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314471
10.
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
JAMA
; 330(20): 1961-1970, 2023 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38015220
11.
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic.
Lancet Oncol
; 23(12): e544-e551, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36455583
12.
Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma.
Eur J Nucl Med Mol Imaging
; 49(8): 2972-2982, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35471254
13.
Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissection.
BMC Cancer
; 22(1): 1129, 2022 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36329397
14.
Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma.
BMC Cancer
; 22(1): 880, 2022 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953777
15.
First-Line Immunochemotherapy Versus Palliative Chemotherapy Plus Definitive Radiation Therapy for de novo Metastatic Nasopharyngeal Carcinoma: A Matched Cohort Study.
Cancer Control
; 29: 10732748221124868, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36047451
16.
Determining the suitability of definitive radiation therapy in patients with metastatic nasopharyngeal carcinoma based on PET/CT: a large cohort study.
Eur Radiol
; 32(11): 7722-7732, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35505116
17.
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.
Eur J Nucl Med Mol Imaging
; 48(8): 2586-2598, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33420610
18.
Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy.
BMC Cancer
; 21(1): 534, 2021 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33975558
19.
Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma.
BMC Cancer
; 21(1): 1320, 2021 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34886807
20.
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Eur Radiol
; 31(7): 5222-5233, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33416977